chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report was received from a health professional on 12/17/03 concerning a 4 year old female vaccinee who experienced swelling and redness that began at the back of her left hand and spread to her left forearm 3-4 hours after receiving Fluvirin vaccine on 12/16/03. On 12/16/03 the vaccinee experienced swelling and redness that started at the back of her left hand and spread to her left forearm. The vaccinee did not experience pruritus or pain. The swelling and redness of her left forearm resolved on 12/17/03. However, the vaccinee still complained of redness at the back of her hand. The vaccinee did not receive any treatments. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Incorrect vaccine given.  Given Bivalent booster 0.3ml (patient 11years of age) No symptoms noted waited 15 min in waiting room.
allergic reaction; dizziness/dizziness only occurs when she is walking and not sitting; weakness; overall not feeling well; This is a spontaneous report from a contactable consumer. A 73-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1, via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  Medical history included hypersensitivity from an unknown date and unknown if ongoing COVID vaccine that she would have a reaction to any COVID vaccine due to her list of other allergies. The patient's concomitant medications were not reported.  The patient received the BNT162B2 at a pharmacy. The patient states she did not have the typical reactions but she had dizziness, weakness, and overall not feeling well on unknown date. The patient states she saw in the FactSheet that this was an allergic reaction to the vaccine. The patient reported her dizziness only occurs when she is walking and not sitting. The patient states she did not have a fever and she did not drive at first but she is driving now. Outcome of the events was unknown.  Information on the Batch/Lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021462195 Same patient/ vaccine, different dose/AE
pt recv vax 18DEC97 10AM & began to have a rash (red, raised, tiny) w/ c/o tingling & numbness rt hand;referred to MD;later in evening began nausea w/emesis;f/u 720AM 19DEC reveals pt is well & @ work;
The patient has a history of uterine cancer and ovarian cancer. She was brought to the ED by EMS on 9/30/23 for evaluation after a fall. She was trying to use the bathroom at home, fell, and hit her head. Her husband additionally reported that he tested positive for COVID 5 days prior. A COVID PCR test resulted positive for the patient while in the ED. Ultimately, the patient was admitted 9/30/23 - 10/9/23, with discharge diagnoses including mild COVID-19 and increased agitation and behavioral disturbances secondary to acute COVID-19 infection, among other diagnoses. During admission, she remained on room air. She was not started on steroid therapy. Of note, the patient has received four doses of the Pfizer Monovalent COVID vaccine (3/1/2021; 3/22/2021; 10/15/2021; 7/15/2022).
RED SWELLING AT INJECTION SITE, MAINLY CONCERNED WITH HEAD STUFF --DIZZY, NAUSEOUS, COULDN'T CONCENTRATE, HEAD ACHE, VISION AFFECTED ( COULDNT SEE WELL.) SYMPTOMS WOULD BE THERE FOR HOURS, THEN GO AWAY. A WEEK LATER, SHE SAYS ITS GETTING BETTER NOW 11/5/21.
Since I received the vaccine I have my period three times in one month. Every month I am going through the same situation.; Also, my period is heavier and different than before I received the vaccine.; This is a spontaneous report received from a contactable reporter (consumer or other non-HCP) . The reporter is the patient.  A 37-year-old female patient received bnt162b2 (COVID-19 VACCINE - MANUFACTURER UNKNOWN) (Lot number: unknown) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing) and "Fibromyalgia" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN, Lot number: UNKNOWN, Route of administration: Unspecified), for COVID-19 immunisation.  The following information was reported: POLYMENORRHOEA (non-serious) with onset 24Sep2021, outcome "not recovered", described as "Since I received the vaccine I have my period three times in one month. Every month I am going through the same situation"; HEAVY MENSTRUAL BLEEDING (non-serious) with onset 24Sep2021, outcome "not recovered", described as "Also, my period is heavier and different than before I received the vaccine". Therapeutic measures were not taken as a result of polymenorrhoea and heavy menstrual bleeding.  Additional Information: The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The lot number for BNT162b2 was not provided and will be requested during follow up.
pt given 0.5ml per age given at checkin found out after the fact pt only 7 and should have received 0.25ml
MENTAL FOGGINESS; LETHARGY; WARM FEELING IN ARM; TINGLING FEELING IN ARM; HEAVY BODY FATIGUE; MILD TO MODERATE ACHES AT INJECTION SITE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced mental fogginess, lethargy, warm feeling in arm, tingling feeling in arm, heavy body fatigue, and mild to moderate aches at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the heavy body fatigue, lethargy, mental fogginess, mild to moderate aches at injection site, warm feeling in arm and tingling feeling in arm was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case assessed as non-serious.
Pt was given the PREVNAR vaccine on Oct 14th, and she developed a patch of redness on her arm below the area where the PREVNAR vaccine was given. She has had the patch of redness for the last 3 days (18th, 19th, and 20th). She also said that she has red itchy bumps on the trunk of her body. Pt said she was not sure if the itchy bumps were from the vaccine or if they were from working out in the yard & being around bugs. I recommended she call her physician and let them know about the reaction and also suggested she try hydrocortisone cream for the itchy bumps.
Left leg swelled at site shot (DTaP) was given, 2 days after shot was given. It had gone down 2 days later (swelling was almost as big as entire thigh).
after he had the second injection he has not had to use anything, it seems like it's gone; This is a spontaneous report from a contactable consumer (Patient).   A 77-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: RN5318, Expiry date was not reported), via an unspecified route of administration on 30Jan2021 (at the age of 77-years-old) as dose 2, single for COVID-19 immunization. The Patient Medical history included arthritis from an unknown date and unknown if ongoing he had arthritis which was self-diagnosed it his hands for quite a while and he had been using copper infused gloves and sometimes if the pain was very bad, he would put cannabis cream on them to ease the pain, blood pressure abnormal from an unknown date and unknown if ongoing. The patient concomitant medications not reported. Previously patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot Number: EL3246 and Expiry date was not reported), via an unspecified route of administration on 09Jan2021 (at the age of 77-years-old) as dose 1, single for COVID-19 immunization. The patient not received other products. Caller is calling about the Pfizer vaccine, the COVID vaccine. He had 2 injections on the 09Jan2021 and second on 30Jan2021. He did not have a adverse reaction, he had a positive reaction. He had arthritis which was self-diagnosed it his hands for quite a while, and he had been using copper infused gloves and sometimes if the pain was very bad, he would put cannabis cream on them to ease the pain. But after he had the second injection, on unspecified date, he has not had to use anything, it seems like it's gone, and he was wondering if there had been any other reactions like that where a condition seems to have improved. He says as long as there won't be 17 calls ahead of him. He says if it is, it is fine, he will drop it. He asks is it possible to have someone call him back. If he can be transferred to someone now otherwise. He had trouble on the web site sending something, he wanted to call but he doesn't want to make this his life's work. But after he had the second injection, he has not had to use anything, it seems like it's gone, and he was wondering if there had been any other reactions like that where a condition seems to have improved. Primary Care: The phone number is in his phone, and he is not able to get it right now. He thinks she is at. He thinks that is it. Patient details: he will be 78 soon. He used to be 6'3 he may be a little less than that now, they say you lose an inch every now and then, but he has good posture so maybe not. The only medication he takes if for blood pressure daily shouldn't have anything to do with that. He says he would rather have someone call him back since call handler does not know whether he would have to hold in a queue or not. The outcome for the event was unknown.  No follow-up attempts are needed. No further information is expected.
Patient discharged after (3) day inpatient admission.  The patient is a 51-year-old lady who presented to the hospital with chief complaint of worsening shortness of breath and cough.  The patient has the past medical history of type 2 diabetes mellitus, hypertension, psoriasis on methotrexate, GERD, hypothyroidism, chronic obstructive pulmonary disease, morbid is 3 common current tobacco abuse.  The patient stated she had developed the symptoms on Tuesday in the form of intermittent productive cough, progressive worsening shortness of breath, intermittent wheezing intermittent fevers and chills with nasal congestion, sore throat and decreased appetite, nausea, myalgia, generalized weakness and fatigue.  Denies any loss of taste or smell.  The patient also complained of some pleuritic chest pain.  Denies any recent medication changes patient is fully vaccinated and received a booster in August.  The patient does not use oxygen at home for her chronic obstructive pulmonary disease.  Denies any lightheadedness or dizziness or headache abdominal pain.  She did have some a minor bilateral pedal edema over the last few days.  Sh patient was found to be hypoxic with tachycardia and hypertension in the emergency department.  She was started on 3 L of nasal cannula to maintain her oxygen saturation.  She was found to have positive COVID PCR.  X-ray chest showed finding suggestive of pulmonary edema a bilateral mixed interstitial/airspace pneumonia.  She was started on IV Solu-Medrol and nebulizer treatments.  He was also started on Lasix.  The she underwent a CT angiogram of the thorax which did not reveal any pulmonary embolism.  However the multifocal tree-in-bud opacity, lung nodularity and interstitial thickening which is similar to the prior exams.  Concern for sarcoidosis was raised.  There was also evidence of right small pleural effusion and small pericardial effusion.  Patient also was found to have worsening mild mediastinal and hilar adenopathy is likely reactive.  She was started on a remdesivir as well for COVID.  Pulmonary service was consulted for concerns of lymphadenopathy, sarcoidosis expressed on the CT scan.Patient was seen by Pulmonary and they will follow her up as outpatient.Further workup once she recovers with repeat CT chest after 3 months.  Patient did well overall.  Her diabetes was managed.  She was subsequently discharged home
Chills, Headache, Joint pains, Fatigue, Nausea, vomitting, diarrhea , abdominal pain, and rash
site reaction; red, warm to touch, swollen, burning, itching; lasted approx 2 weeks after vaccine; treated with hydrocortisone, ice, and ibuprofen
No additional AEs reported; an adult patient receiving a pediatric dose of VAQTA; an adult patient receiving a pediatric dose of VAQTA; This spontaneous report was received from a pharmacist and refers to an adult patient of unknown gender and exact age. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 22-JAN-2021, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) syringe injection, 25 U/0.5 ml, 1 pediatric dose (route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age and incorrect dose administered).  The pharmacist was inquiring on next steps for an adult patient receiving a pediatric dose. No additional adverse event was reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
ACUTE STROKE DUE TO OCCLUSION OF RIGHT CEREBELLAR ARTERY REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME
pt devel OM 1 day p/vax;pt was treated w/PCN x 10 days & recovered;
I woke up 8 days after my second dose covered head to toe with hives.  My eye was also swollen shut.  I have seen 3 doctors who all agreed that it was from the vaccine.  I have been heavily medicated for the past 6 months trying to control the hives and itching which I still currently have.  Prior to the vaccine, I had never had hives, or any sort of allergies.
severe swelling & redness about 2 inches in diameter lasted 8-9days-red & inflamed & redness around the large lesion in the middle;still having small lumps p/3hr;site of inj checked by MD 20MAR98;
This spontaneous report as received from a nurse refers to a female patient of unknown age. On 01-OCT-2014 the patient was vaccinated with dose 1 GARDASIL (Injection, lot # K009811, exp 16-JUN-2016). The patient's mother called the physician's office and spoke to the anonymous nurse to report that the patient had a stomach ache and leg pain after receiving the GARDASIL injection. The mother reported that the patient would no longer receive any further GARDASIL therapy. The patient did not receive treatment. The outcome of leg pain and the patient had a stomach ache was unknown. Additional information has been requested.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe, Additional Details: Patient stated that exactly 24 hours after his dose, he had a "big" lip. He described it as swollen and itchy. He went to an urgent care where they gave him "2 shots in the butt, steroids, and benadryl." He is still taking benadryl to help with the itchiness. He also stated that he had to take off work today due to his reaction.
Approximately 11-12 hours after vaccination (2-3 AM), i woke up with many usual symptoms (headache, nausea, swollen lymph nodes, stiff neck, etc.) and one symptom that I have not heard about : muscle cramps & twitching. I also had this symptom after the first vaccination. Both times the onset of muscle cramps & twitching started approx 12 hours post injection and lasted for a total of 24 hours thereafter.
Patient ran fever greater than 102 degrees, muscles aches, nausea, headache, chills lasting until 11/19/18.
Cold, runny nose; Cold, runny nose; Bleeding from nose; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold, runny nose), RHINORRHOEA (Cold, runny nose), EPISTAXIS (Bleeding from nose), PYREXIA (Fever) and CHILLS (Chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was provided by the reporter  .     On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold, runny nose), RHINORRHOEA (Cold, runny nose), EPISTAXIS (Bleeding from nose), PYREXIA (Fever) and CHILLS (Chills). The patient was treated with GUAIFENESIN (MUCINEX) ongoing since an unknown date at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (Cold, runny nose), RHINORRHOEA (Cold, runny nose), EPISTAXIS (Bleeding from nose), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported. Treatment medication reported included garlic.
Employee developed redness swelling and warmth and itching to left deltoid reaction started  11 days after vaccine administration per employee Pfizer Vaccine was administered
Started with raised red rash circling the injection site, and has been getting bigger everyday. Pain and itchy in rash area, pain deep inside my armpit, (maybe swollen lymph noid) frequent sweating under arms and hands
patient that had been diagnosed with shingles, received the Shingrix vaccine to treat her; This case was reported by a pharmacist via call center representative and described the occurrence of off label use in a 92-year-old female patient who received Herpes zoster (Shingrix) (batch number N3S45, expiry date 27th May 2023) for prophylaxis.   Concurrent medical conditions included shingles.   On 18th February 2022, the patient received the 1st dose of Shingrix. On 18th February 2022, unknown after receiving Shingrix, the patient experienced off label use. On an unknown date, the outcome of the off label use was unknown.   Additional Information: GSK Receipt Date: 15-APR-2022 Reporter's comment: The registered pharmacist reported that a patient that had been diagnosed with shingles who came to pharmacy and received Shingirx vaccine to treat shingles. The patient denied at that time of vaccination having any illness but then later became aware of the situation. The reporter consented to follow up. Additional Supportive Information: The reporter said, a patient that had been diagnosed with shingles who came to pharmacy and received Shingirx vaccine to treat shingles, which led to off label use. The Vaccine Administration Facility is the same as primary reporter.
severe pain, swelling to injection site that turned into cellulitis causing need for antibiotic treatment
Patient was given a Hep A vaccination instead of a Hep B on 1-16-15. Patient had no reaction that was reported by parent and patient's next appointment was on 3-24-15 for a well visit.
Allergic reaction on the right arm about 1 inch in diameter spread around, red, itching but no pain and is not going away from a week now, MD told her to take CLARITIN and the rash is gone.
Information has been received from a consumer concerning his 74 year old wife with no known allergies and high blood pressure who on an unspecified date in October 2007, was vaccinated with 0.65ml of zoster vaccine live (Oka/Merck). Subsequently, within 10 days after getting zoster vaccine live (Oka/Merck), the patient developed nerve pain. Unspecified medical attention was sought and the patient had "tests" performed (results not provided). At the time of the report the patient was not recovered. There was no product quality complaint involved. No further information is available,
Information has been received from a physician concerning an adult female with chronic asthma who in October 2004, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 649732/0513P). Subsequently, the patient developed swelling of the upper arm with redness, fever, chills and headache. The physician reported that the patient was to be seen in the office on Oct 29 2004. The physician reported 3 other patients who had similar reaction post vaccination with pneumococcal 23v polysaccharide vaccine (lot 649732/0513P) (WAES0411USA00004, WAES0411USA01789). Additional information has been requested.
My body itches, both arms, at the wrists,both nipples, abdomen. The left side of my neck hurts,  and I feel a lump to the lower left side of my neck and it's painful to touch
Stroke,treated by neurologist,Dr. Discharged on Feb. 15th 2021 and am taking therapy.Loss of blood circulation and oxygen in left side of brain.After the stroke,an ambulance was called to transport me to the E.R. E.R. then transported to the Medical Center
(L) arm swollen from elbow to shoulder; Warm to touch. Acute onset (within 2-3 hours post injection). Resolved in 4 days.
This spontaneous report was received from a registered nurse concerning an unspecified number of patients of unknown demographics. On an unknown date, unspecified number of patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot number, expiry date, dose and route unspecified). No concomitant therapy was reported. No symptoms were reported. This is one of the several reports from the same source. Additional information has been requested.
Unexplained nerve pain in arms, right knee and both ankles. This came on after the second shot, but I don't know if it's related to it. After the covid vaccine, one month later, I began Mavyret, and completed it. My doctor has no explanation for it, and has me going to orthopedic doctors to dig further into what is going on. I had no related I juries or health problems and it came on suddenly. It debilitated me, and I was unable to walk. My doctor out me on Diclofenac and a muscle relaxer and it's reduced the pain greatly. Also had x-rays, they show nothing. The nerve sensation is now very faint in my lips and hands.
Case number PHEH2014US012461 is an initial spontaneous report received from a health care professional on 18 Jun 2014 with a follow-up received on 21 Jul 2014. This report refers to a 21 year old female patient. Her past medical history and concomitant medications were not reported. She was vaccinated with 0.5 ml of MENVEO (batch number: X11032) intramuscularly into left deltoid on 16 Jun 2014 at 11:15 am. However, the Men A lyophilized conjugate component of the vaccine was reconstituted with an expired Men CYW 135 liquid component. No adverse events were reported following the administration of expired vaccine. Follow-up received from a health care professional on 21 Jul 2014: Dose, site and time of vaccination updated.
Impaired speech, (mumbling, distorted sound), droopy right side of face, no right side forehead wrinkles when tried to raise eyebrows, frozen right eyebrow, lower right eyelid droop, couldn't close top and bottom eyelids, right cheek droop, right-side of mouth droop/slack. Initially thought stroke. But CT scan, MRI and ultra sound of heart ruled out. Was in hospital for observation and tests from Mon May 10 until Tues May 11. Diagnosed as Bells Palsy. Took large doses of Prednisone that tapered off for 10 days. Symptoms resolved after 5 weeks.
Inadvertently gave inactivated polio intradermally when I thought I was giving at TB test. IPOL box and PPD box looks very similar.